The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks
Mohammed S. I. Mansour,Louise Pettersson,Tomas Seidal,Ulf Strömberg,Ulrich Mager,Lana Ali,Sana Kumbaric,Kim Hejny,Fereshteh Taheri‐Eilagh,Joudy Mufti,Dawla Nakdali,Hans Brunnström
DOI: https://doi.org/10.1002/cncy.22833
2024-06-04
Cancer Cytopathology
Abstract:Background Cell blocks (CBs) are widely used for biomarker analyses such as immunostaining. Although immunohistochemistry on formalin‐fixed paraffin‐embedded tissues is standardized, there are multiple preparation methods and fixatives for cytology. Our objective was to investigate the effect of different common fixatives on the immunoreactivity of pleural effusion CBs with metastatic lung adenocarcinomas. Methods This prospective study included 24 malignant pleural effusions from different patients with lung adenocarcinoma. From each case, four identical CBs were fixed in 10% neutral buffered formalin, PreservCyt, CytoLyt, and CytoRich Red (only 17 of the cases), respectively. Samples containing <100 malignant cells were excluded. All CBs were stained with thyroid transcription factor 1 (TTF‐1; clones 8G7G3/1 and SPT24), napsin A, claudin 4, CEA, CK7, and epithelial cell adhesion molecule (EpCAM; clones BS14, Ber‐Ep4, and MOC‐31). The fraction and intensity of stained cells were evaluated. Results Of the investigated markers, a significant difference in staining proportion was seen for TTF‐1 clone 8G7G3/1 and EpCAM clone MOC‐31, especially with cases being negative in CytoLyt (33.3% and 83.3% positive, respectively) and PreservCyt (62.5% and 83.3%) whereas being positive in CytoRich Red (76.5% and 94.1%) and formalin (both 95.8%). A significantly weaker intensity of staining was seen for all alcohol‐based fixatives compared to formalin for TTF‐1 clone 8G7G3/1, napsin A, and EpCAM clone MOC‐31, whereas EpCAM clone Ber‐Ep4 was significantly weaker only in PreservCyt compared with formalin. Conclusions Immunocytochemical expression and concordance with formalin‐fixed CBs differ depending on the used fixative as well as the antibody and clone, warranting investigation of the reliability of each biomarker for non–formalin‐fixed cytology.
oncology,pathology